Wednesday, January 4, 2023

Diagnostic potential of the amniotic fluid cells RNA-sequencing in deciphering rare diseases

New research leads the discovery of applying amniotic fluid cells obtained during 16-24 weeks of pregnancy as a novel sample type for RNA-sequencing in prenatal diagnosis to help more families with tailored clinical management. This is a proof-of-concept study to demonstrate the potential clinical utility of amniotic fluid cells RNA-sequencing in the literature.

from Top Health News -- ScienceDaily https://ift.tt/blQcT3i

No comments:

Post a Comment

Scientists just mapped the mutations that power cancer growth

Researchers have created the first complete map showing how hundreds of mutations in a key cancer gene affect tumor growth. By testing every...